Recent Quotes (30 days)

You have no recent quotes
chg | %

IntelGenx Technologies Corp.  

(Public, OTCMKTS:IGXT)   Watch this stock  
Find more results for OTC:IGXT
+0.030 (6.12%)
Delayed:   2:35PM EDT
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.50 - 0.52
52 week 0.33 - 0.90
Open 0.50
Vol / Avg. 110,195.00/107,819.00
Mkt cap 42.34M
P/E     -
Div/yield     -
EPS -0.02
Shares 63.62M
Beta 69.29
Inst. own     -

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin -47.01% -105.24%
Operating margin -44.62% -107.29%
EBITD margin - -102.83%
Return on average assets -19.57% -27.93%
Return on average equity -26.56% -36.45%
Employees 12 -
CDP Score - -


6425 Abrams
+1-514-3317440 (Phone)

Website links


IntelGenx Technologies Corp. is a Canada-based drug delivery company focusing on the development of novel, orally administered drug delivery products based on its proprietary oral drug delivery technologies. The Company has positioned themselves as a provider of product development services for the pharmaceutical industry, including the branded and generic pharmaceutical markets. The Company’s products under development focus on controlled release delivery systems. Controlled release delivery systems play an important role in the development of orally administered drug delivery systems. Controlled release technology provides patients with the required amount of medication over a pre-determined, prolonged period of time. The Company’s product development efforts are based upon three delivery platform technologies: VersaFilm, an Oral Film technology; VersaTab, a Multilayer Tablet technology and AdVersa, a Mucoadhesive Tablet technology.

Officers and directors

J. Bernard Boudreau QC Vice Chairman of the Board, Independent Director
Age: 70
Andre Godin CPA Chief Financial Officer, Executive Vice President
Ingrid Zerbe Director - Finance and Administration, Corporate Secretary
Age: 60
John Edward Durham Vice President - Manufacturing Operations
Age: 60
Horst G. Zerbe Ph.D. Chairman of the Board, President, Chief Executive Officer
Age: 68
Clemens Mayr Director
Age: 47
John Marinucci CPA Independent Director
Age: 58
Bernd J. Melchers Independent Director
Age: 63
Ian Troup Independent Director
Age: 72